老年创伤患者钝性脾损伤非手术治疗安全吗
该研究回顾性分析2014年美国国家创伤数据库(NTDB)中钝性脾损伤患者,排除入院6小时内行脾切除者,比较年轻(<65岁)与老年(≥65岁)患者非手术治疗失败率及死亡率。共纳入18917例,其中老年2240例(12%),年轻16677例(88%)。老年患者非手术治疗失败率6%,高于年轻患者的4%(p<0.0001)。 logistic回归显示,损伤严重度评分≥16是老年患者非手术治疗失败的独立危险因素(OR 2.778,95%CI 1.769-4.363,p<0.0001)。老年患者中,非手术治疗成功者死亡率11%,失败者15%,差异无统计学意义(p=0.22);非手术治疗失败并非死亡的独立危险因素(OR 1.429,95%CI 0.776-2.625,p=0.25)。作者结论认为老年钝性脾损伤患者非手术治疗是安全的。
要点
- 老年(≥65岁)钝性脾损伤患者非手术治疗失败率6%,高于年轻(<65岁)患者的4%(p<0.0001)。
- 损伤严重度评分≥16是老年患者非手术治疗失败的独立危险因素(OR 2.778,95%CI 1.769-4.363,p<0.0001)。
- 老年患者中非手术治疗成功者死亡率11%,失败者15%,差异无统计学意义(p=0.22)。
- 非手术治疗失败并非老年患者死亡的独立危险因素(OR 1.429,95%CI 0.776-2.625,p=0.25)。
- 作者认为基于该结果,老年钝性脾损伤患者非手术治疗是安全的。
适用人群与场景
- 2014年国家创伤数据库(NTDB)中诊断为钝性脾损伤的年轻(年龄<65岁)与老年(年龄≥65岁)患者。
- 排除入院6小时内行脾切除的患者。
研究设计与关键结果
- 回顾性分析2014年国家创伤数据库(NTDB)数据,共纳入18917例钝性脾损伤患者,其中老年(≥65岁)2240例(12%),年轻(<65岁)16677例(88%)。
- 老年患者非手术治疗失败率6%,高于年轻患者的4%(p<0.0001)。
- logistic回归显示,损伤严重度评分≥16是老年患者非手术治疗失败的唯一独立危险因素(OR 2.778,95%CI 1.769-4.363,p<0.0001)。
- 老年患者中非手术治疗成功者死亡率11%,失败者15%,差异无统计学意义(p=0.22)。
- 老年患者死亡的独立危险因素包括入院低血压、损伤严重度评分≥16、格拉斯哥昏迷评分≤8及心脏病;非手术治疗失败并非死亡的独立危险因素(OR 1.429,95%CI 0.776-2.625,p=0.25)。
证据类型、等级与局限
- 证据类型:回顾性分析(国家创伤数据库数据)。
- 证据等级:治疗性研究,level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于该结果,老年钝性脾损伤患者非手术治疗是安全的。
- 老年患者非手术治疗失败率高于年轻患者但数值接近(6% vs 4%),且失败率低于既往报道。
- 损伤严重度评分≥16的老年钝性脾损伤患者非手术治疗失败风险更高(OR 2.778,95%CI 1.769-4.363)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Because of increased failure rates of nonoperative management (NOM) of blunt splenic injuries (BSI) in the geriatric population, dogma dictated that this management was unacceptable. Recently, there has been an increased use of this treatment strategy in the geriatric population. However, published data assessing the safety of NOM of BSI in this population is conflicting, and well-powered multicenter data are lacking.
METHODS: We performed a retrospective analysis of data from the National Trauma Data Bank (NTDB) from 2014 and identified young (age < 65) and geriatric (age ≥ 65) patients with a BSI. Patients who underwent splenectomy within 6 hours of admission were excluded from the analysis. Outcomes were failure of NOM and mortality.
RESULTS: We identified 18,917 total patients with a BSI, 2,240 (12%) geriatric patients and 16,677 (88%) young patients. Geriatric patients failed NOM more often than younger patients (6% vs. 4%, p < 0.0001). On logistic regression analysis, Injury Severity Score of 16 or higher was the only independent risk factor associated with failure of NOM in geriatric patients (odds ratio, 2.778; confidence interval, 1.769-4.363; p < 0.0001). There was no difference in mortality in geriatric patients who had successful vs. failed NOM (11% vs. 15%; p = 0.22). Independent risk factors for mortality in geriatric patients included admission hypotension, Injury Severity Score of 16 or higher, Glasgow Coma Scale score of 8 or less, and cardiac disease. However, failure of NOM was not independently associated with mortality (odds ratio, 1.429; confidence interval, 0.776-2.625; p = 0.25).
CONCLUSION: Compared with younger patients, geriatric patients had a higher but comparable rate of failed NOM of BSI, and failure rates are lower than previously reported. Failure of NOM in geriatric patients is not an independent risk factor for mortality. Based on our results, NOM of BSI in geriatric patients is safe.
LEVEL OF EVIDENCE: Therapeutic, level IV.
参考来源
- Trust MD, Teixeira PG, Brown LH, et al. Is It safe? Nonoperative management of blunt splenic injuries in geriatric trauma patients. J Trauma Acute Care Surg. 2018. PMID: 29077678. doi:10.1097/TA.0000000000001731
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。